HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rituximab for the treatment of extranodal marginal zone B-cell lymphoma of the lacrimal gland.

AuthorsCarsten Heinz, Hartmut Merz, Matthias Nieschalk, Heribert Mueller-Miny, Peter Koch, Arnd Heiligenhaus
JournalThe British journal of ophthalmology (Br J Ophthalmol) Vol. 91 Issue 11 Pg. 1563-4 (Nov 2007) ISSN: 0007-1161 [Print] England
PMID17947275 (Publication Type: Case Reports, Letter)
Chemical References
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents
  • Rituximab
Topics
  • Antibodies, Monoclonal (therapeutic use)
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents (therapeutic use)
  • Female
  • Humans
  • Lacrimal Apparatus Diseases (drug therapy)
  • Lymphoma, B-Cell, Marginal Zone (drug therapy)
  • Magnetic Resonance Imaging
  • Middle Aged
  • Rituximab

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: